Submitted by pattersonj on Fri, 03/06/2015 - 13:10
Biomedical research at universities produces a steady stream of promising new pharmaceuticals and medical procedures, and clinical trials are a critical step in assessing their efficacy and safety before taking them to market.
But the process and negotiations involved in getting those trials off the ground—especially for studies taking place at multiple sites simultaneously—can be daunting.
Submitted by pattersonj on Fri, 03/06/2015 - 10:41
Sen. Harkin visits UI researchers, is committed to finding more federal research dollars